Prescient Therapeutics LimitedASX: PTX

PTX-200 AML Trial Progresses to Next Dose Level

Aug 3, 2020 at 4:53 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment